FDA label

What is Alphagan P used for?

Alphagan P contains brimonidine. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.

Source: DailyMed SPL label file dated 2026-10-23. Publisher page

The FDA label says: “ALPHAGAN P (brimonidine tartrate ophthalmic solution) 0.1% or 0.15% is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.”

Run it in Rivvi

Which 2027 plans near you dropped or restricted Alphagan P?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Alphagan P, solution/ drops

Indications and Usage, quoted from the label by Allergan, Inc. (NDA021262). Cross-references to other label sections are left out.

ALPHAGAN P (brimonidine tartrate ophthalmic solution) 0.1% or 0.15% is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

Source: DailyMed label, set id 264c4494-c225-486f-888a-caaf36be46b3, version 25, effective September 18, 2025. NDC 0023-9177, one of 2 listings for this product.

Questions

What is Alphagan P used for?

The FDA label says: “ALPHAGAN P (brimonidine tartrate ophthalmic solution) 0.1% or 0.15% is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.”

What drug class is Alphagan P?

FDA lists brimonidine in the alpha-Adrenergic Agonist established pharmacologic class.

Does this page cover off-label uses or dosing?

No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.

More on Alphagan P

Try it on your own data today.

Free to start. Most teams are using it the same day.